Navigation Links
Fufeng Announces 2007 Annual Results
Date:4/21/2008

Turnover Increased by 37%

HONG KONG, April 22 /Xinhua-PRNewswire/ -- Fufeng Group Limited ("Fufeng" or "the Company", together with its subsidiaries collectively known as "the Group"; HKEx: 546), a leading vertically integrated manufacturer of corn-based biochemical products in China, announced its annual results for the year ended 31 December 2007.

During the year, driven by the increased sales volume of major products, the Group's turnover increased to RMB2,445.7 million, representing an increase of 37% compared to 2006. However, with the decrease in the average selling prices (ASP) of the Group's major products and the increase in the cost of raw materials, especially corn kernel, the Group's gross profit dropped to RMB249.7 million. The increase in transportation, administrative expenses also further lowered the Group's profitability. Fufeng recorded a profit attributable to shareholders for 2007 of approximately RMB 45.1 million. Its earnings per share for 2007 amounted to RMB 2.8 cents.

Commenting on the results, Mr. Li Xuechun, Chairman of Fufeng said, "Despite the challenging market conditions in 2007, the Group managed to maintain its leading position in the corn-based fermentation industry. During the year, we strived to capture the opportunity brought by MSG and glutamic acid industry consolidation and actively expand our market, our market share in the sector surged significantly to 23% in 2007 from 17% in 2006. As for xanthan gum, the Group actively expanded export business, the export portion of xanthan gum increased from 65% to 83%. Other than better selling price, the Group can also enlarge our market share in xanthan gum through exporting products."

During the period, the Group posted a healthy increase for its MSG segment. The sales volume of MSG increased by nearly 200% to 91,850 tonnes, this proves the Group's decision to shift its focus from glutamic acid to MSG production. Besides, fertilisers also recorded strong growth of 68% to reach 419,422 tonnes. Sales volume of xanthan gum increased by 14% to 6,216 tonnes; as the 10,000 tonnes xanthan gum production line in Inner Mongolia Plant only commenced operation in September 2007, it is expected that the Group will record strong growth in xanthan gum sales in 2008.

When talking about the Group's future strategies, Mr. Li said, "We believe we will overcome the difficulties in 2008; it is expected that the restructuring of MSG market will come to an end in 2008. Then the supply of MSG products will be stabilised and therefore the price may go up. With our self-produced glutamic acid and economies of scale, Fufeng will remain as the leading player in the market. Meanwhile, we believe that the xanthan gum market supply will stabilise this year whilst the demand will grow for more customers realize the advantages of the products. As xanthan gum production consumes less corn kernel, and our Inner Mongolia Plant enjoys low coal cost advantage, our production cost will decrease as we expand xanthan gum production. In the meantime, we will also increase domestic and export sales of xanthan gum as well as xanthan gum production capacity. We planned to increase xanthan gum production capacity to 28,000 tonnes at the end of 2008 or first half of 2009, by then, the Group will become one of the major xanthan gum manufacturers in the world."

"We will further consolidate and strengthen our leading position in the MSG segment and xanthan gum segment by leveraging our competitive strengths. Our ultimate goal is to become a leading corn-based biochemical product manufacturer in China and deliver satisfactory returns for our shareholders," Mr. Li concluded.

About Fufeng Group Limited

Fufeng is one of the leading vertically integrated manufacturers of corn- based biochemical products principally utilising fermentation technology in China, and mainly engaged in MSG related products and xanthan gum production. MSG segment includes production of MSG, glutamic acid, fertilisers, corn refined products and sweeteners. Fufeng is the largest glutamic acid producer, and the second largest xanthan gum manufacturer in China in terms of production volume. You might visit the Company website for more details: http://www.fufeng-group.com .

For more information, please contact:

iPR Ogilvy Ltd.

Callis Lau/ Tina Law

Tel: +852-2136-6952/ +852-2136-6181

Email: callis.lau@iprogilvy.com/ tina.law@iprogilvy.com


'/>"/>
SOURCE Fufeng Group Limited
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
(Date:6/23/2016)... -- Andrew D Zelenetz , ... Published recently in Oncology & ... Andrew D Zelenetz , discusses the fact ... placing an increasing burden on healthcare systems worldwide, ... the patents on many biologics expiring, interest in ...
(Date:6/23/2016)... Francisco, CA (PRWEB) , ... June 23, 2016 ... ... (EDC) software, is exhibiting at the Pennsylvania Convention Center and will showcase its ... Annual conference. ClinCapture will also be presenting a scientific poster on Disrupting Clinical ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... line of intelligent tools designed, tuned and optimized exclusively for Okuma CNC machining ... Chicago. The result of a collaboration among several companies with expertise in toolholding, ...
Breaking Biology Technology:
(Date:4/28/2016)... SAN FRANCISCO and BANGALORE, India ... part of EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... service provider, today announced a global partnership that ... convenient way to use mobile banking and payment services. ... Mobility is a key innovation area for financial services, but ...
(Date:4/19/2016)... DUBAI , UAE, April 20, 2016 ... can be implemented as a compact web-based "all-in-one" system ... in the biometric fingerprint reader or the door interface ... requirements of modern access control systems. The minimal dimensions ... the ID readers into the building installations offer considerable ...
(Date:4/13/2016)... physicians supporting Medicaid patients in Central Florida ... telehealth thanks to a new partnership with higi.   ... can routinely track key health measurements, such as blood ... they opt in, share them with IMPOWER clinicians through ... location at no cost. By leveraging this data, IMPOWER ...
Breaking Biology News(10 mins):